[1]
M. Hazra, “A pharmacoepidemiological study of prescription patterns of β2 sympathomimetic bronchodilators in exacerbation of non-severe asthma in tertiary care hospitals, not needing hospitalization”, Int J Basic Clin Pharmacol, vol. 8, no. 12, pp. 2674–2680, Nov. 2019.